1.Clinical study of "total laparoscopic pancreaticoduodenectomy" in low-flow hospitals
Quan MAN ; Huifang PANG ; Yaming GUO ; Zhiyuan SHAO ; Yanzhe CHEN ; Xiangjun QI
International Journal of Biomedical Engineering 2021;44(4):313-317
Objective:To explore the safety, feasibility and clinical value of the "posterior colon approach, uncinate process first" of total laparoscopic pancreaticoduodenectomy in low volume hospitals.Methods:The clinical data of 3 patients who underwent complete laparoscopic pancreaticoduodenectomy were analyzed from January 2020 to August 2020.Results:All the 3 patients successfully underwent total laparoscopic pancreaticoduodenectomy. For the 3 patients, the operative time was 430, 385 and 425 min, and the blood loss was 550, 420 and 400 ml. After the operation, no pancreatic fistula, bile leakage, intestinal fistula and astric emptying disorder were found in the patients. The exhaust time of the 3 patients was 4, 5 and 5 days after the operation, respectively. On the 6th day after the operation, the gastric tube was removed. The extraction time of the abdominal drainage tube of the 3 patients was the 7th, 7th and the 9th day, and the postoperative hospital stay was 18, 15 and 16 days, respectively. Postoperative pathological diagnosis results showed that the 3 patients included 1 case of pancreatic head high-moderately differentiated ductal adenocarcinoma, 1 case of duodenal ampullary high-moderately differentiated adenocarcinoma, and 1 case of duodenal papillary well-differentiated adenocarcinoma.Conclusions:"Posterior approach of uncinate process" is safe and feasible in laparoscopic pancreaticoduodenectomy. It can be popularized in low volume hospitals.
2.Chinese Medicines Regulate p38 MAPK, ERK1/2, and JNK in Treatment of Osteoporosis: A Review
Yanzhe QI ; Zi WANG ; Hougan OUYANG ; Chu CHEN ; Rongbin PAN ; Xun LIU
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(12):222-229
With the aging of population, osteoporosis has become one of the main diseases endangering the health of the elderly in China. Therefore, the research on osteoporosis has become a hot spot. Since Chinese medicines demonstrate significant therapeutic effects on osteoporosis, this issue is attracting increasing attention from researchers, especially in the deciphering of the molecular mechanism. This paper introduces the mechanism of the prevention and treatment of osteoporosis by Chinese medicines via the mitogen-activated protein kinase (MAPK) signaling pathway, aiming to provide a theoretical basis for deciphering the mechanism of Chinese medicines in the treatment of osteoporosis and promoting their clinical application. MAPK signaling pathway mainly involves p38 MAPK, extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase 5 (ERK5). Studies have shown that these proteins play a role in the progression of osteoporosis by regulating cell proliferation, differentiation, and apoptosis. Chinese medicines as a unique therapy with Chinese characteristics has definite efficacy, high safety, and mild side effects. Researchers have proved by experiments that the extracts or compounds of Chinese medicines can significantly mitigate osteoporosis by regulating the proteins involved in the MAPK signaling pathway. Therefore, this article reviews the relevant studies with focus on these proteins.
3.Treatment of Osteoporosis via Regulation of Endocrine System by Traditional Chinese Medicine: A Review
Zi WANG ; Yanzhe QI ; Rongbin PAN ; Chu CHEN ; Xun LIU ; Hougan OUYANG
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(20):221-229
In recent years, with the changes of population structure and the aggravation of aging, the prevalence of osteoporosis is increasing year by year. Osteoporosis poses great impacts on the body and family life of the patients and increases the burden on the society. Therefore, the research on osteoporosis is urgent and significant. The imbalance between osteoblasts, osteocytes, and osteoclasts causes abnormal bone metabolism, which destroys the fine structure of bone and increases bone fragility, thus increasing the risk of fracture. Although the pathogenesis of osteoporosis is complex, researchers have confirmed that the imbalance of the endocrine system directly or indirectly promotes the occurrence and development of osteoporosis. Traditional Chinese medicine (TCM) is a treasure of Chinese traditional culture and plays a key role in safeguarding the public health. With unique therapeutic effects and advantages, TCM has been widely accepted. Chinese medicines, moxibustion, acupuncture and other TCM therapies have play a unique role in the treatment of osteoporosis. Particularly, TCM prevention and treatment of osteoporosis by regulating the endocrine system has received extensive attention. By reviewing relevant literature, this paper introduces the research progress in the TCM modulation of bone metabolism and alleviation of bone loss by regulating estrogen, calcitonin, and parathyroid hormone in the endocrine system and affecting the hypothalamus capable of regulating these hormones, aiming to provide ideas for the TCM treatment of osteoporosis.
4.Diagnostic utility of electromagnetic navigation bronchoscopy combined with radial endobronchial ultrasound in peripheral pulmonary lesions
Min YU ; Shenyun SHI ; Yan LI ; Yanzhe YU ; Tingting ZHAO ; Qingqing XU ; Qi ZHAO ; Jingjing DING ; Anning FENG ; Jinghong DAI ; Yonglong XIAO
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2022;29(01):44-49
Objective To investigate the diagnostic value and safety of electromagnetic navigation bronchoscopy combined with radial endobronchial ultrasound in peripheral pulmonary nodules. Methods The clinical imaging, surgical and pathological data of 60 patients with 76 peripheral pulmonary nodules who underwent electromagnetic navigation bronchoscopy combined with radial endobronchial ultrasound guided biopsy in the Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School from June 2020 to June 2021 were retrospectively analyzed. The diagnosis rate and complications were analyzed and summarized. The 76 pulmonary nodules were divided into a small pulmonary nodules group (10 nodules, diameter≤1 cm) and a pulmonary nodules group (1 cm